Alabama Supreme Court ruling favors Sandoz in Medicaid pricing case
05:26 EDT 16 Jul 2012 | thePharmaLetter
The USA's Alabama Supreme Court came out in favor of Sandoz, the generics subsidiary of Swiss drug major Novartis (NOVN: VX), overturning the earlier $78.4 Montgomery County Circuit Court's February 2009 jury verdict against the company, ruling on Fr..
Original Article: Alabama Supreme Court ruling favors Sandoz in Medicaid pricing case
More From BioPortfolio on "Alabama Supreme Court ruling favors Sandoz in Medicaid pricing case"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
